Russell Investments Group
RVLP

Russell Investments Group’s RVL Pharmaceuticals plc Ordinary Shares RVLP Stock Holding History

Russell Investments Group’s Portfolio RVLP Stock Details RVLP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-53,973
Closed -$222K – 3215
2020
Q4 		$222K Sell
53,973
-42,411
-44% -$244K ﹤0.01% 2731
2020
Q3 		$521K Buy
96,384
+12,500
+15% +$72K ﹤0.01% 2374
2020
Q2 		$564K Sell
83,884
-3,617
-4% -$17.7K ﹤0.01% 2339
2020
Q1 		$277K Buy
+87,501
New +$466K ﹤0.01% 2435

Other funds holding RVLP

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
SCM
Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return
WCM
Wedge Capital Management Charlotte, North Carolina $6.06B AUM 47.24% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Russell Investments Group's RVLP Position: Q1 2021 in Review

Russell Investments Group sold out of RVL Pharmaceuticals plc Ordinary Shares (RVLP) in Q1 2021, closing a stake of 53,973 shares — an estimated $222K sold.

Russell Investments Group first reported a position in RVLP in Q1 2020 and held it in 4 quarters. The position peaked at $564K in Q2 2020. 55 funds tracked by Wall St. Rank hold RVLP as of Q1 2021.

  • Russell Investments Group reported no remaining RVL Pharmaceuticals plc Ordinary Shares position as of Q1 2021 after selling out during the quarter.
  • Russell Investments Group sold 53,973 RVL Pharmaceuticals plc Ordinary Shares shares in Q1 2021, an estimated $222K.
  • Russell Investments Group first reported a position in RVL Pharmaceuticals plc Ordinary Shares in Q1 2020 and held it in 4 quarters.
  • Russell Investments Group's RVL Pharmaceuticals plc Ordinary Shares position peaked at $564K in Q2 2020.
  • 55 funds tracked by Wall St. Rank held RVL Pharmaceuticals plc Ordinary Shares as of Q1 2021.

Based on Russell Investments Group's 13F filing for Q1 2021, filed 10 May 2021.